{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:49:03Z","timestamp":1789051743160,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T00:00:00Z","timestamp":1302220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T00:00:00Z","timestamp":1302220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Folate receptor beta (FR\u03b2) is only detectable in placenta and limited to some hematopoietic cells of myeloid lineage in healthy people. Studies have indicated that FR\u03b2 is over-expressed in activated macrophages in autoimmune diseases and some cancer cells. In this study we aimed to develop an FR\u03b2-specific human monoclonal antibody (mAb) that could be used as a therapeutic agent to treat rheumatoid arthritis and other autoimmune diseases, as well as FR\u03b2 positive cancers.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Functional recombinant FR\u03b2 protein was produced in insect cells and used as antigen to isolate a mAb, m909, from a human na\u00efve Fab phage display library. Binding of Fab and IgG1 m909 to FR\u03b2 was measured by ELISA, surface plasmon resonance, immune fluorescence staining, and flow cytometry. Antibody-dependent cell-mediated cytotoxicity (ADCC) was evaluated with FR\u03b2 positive CHO cells as target cells and isolated peripheral blood monocytes as effector cells in an <jats:italic>in vitro<\/jats:italic> assay.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Fab m909 bound with relatively high affinity (equilibrium dissociation constant 57 nM) to FR\u03b2. The IgG1 m909 showed much higher (femtomolar) avidity as measured by ELISA, and it bound to FR\u03b2 positive cells in a dose-dependent manner, but not to parental FR\u03b2 negative cells. m909 did not compete with folate for the binding to FR\u03b2 on cells. m909 was not only able to select FR\u03b2 positive, activated macrophages from synovial fluid cells of arthritis patients as efficiently as folate, but also able to mediate ADCC in FR\u03b2 positive cells.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Unlike folate-drug conjugates, m909 selectively binds to FR\u03b2, does not recognize FR\u03b1, and has at least one effector function. m909 alone has potential to eliminate FR\u03b2 positive cells. Because m909 does not compete with folate for receptor binding, it can be used with folate-drug conjugates in a combination therapy. m909 can also be a valuable research reagent.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3312","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T06:14:14Z","timestamp":1302329654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity"],"prefix":"10.1186","volume":"13","author":[{"given":"Yang","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily D","family":"Streaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimiter S","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,8]]},"reference":[{"key":"3097_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","volume":"66","author":"LH Matherly","year":"2003","unstructured":"Matherly LH, Goldman DI: Membrane transport of folates. Vitam Horm. 2003, 66: 403-456.","journal-title":"Vitam Horm"},{"key":"3097_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","volume":"56","author":"H Elnakat","year":"2004","unstructured":"Elnakat H, Ratnam M: Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev. 2004, 56: 1067-1084. 10.1016\/j.addr.2004.01.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"3097_CR3","doi-asserted-by":"publisher","first-page":"e6292","DOI":"10.1371\/journal.pone.0006292","volume":"4","author":"E Basal","year":"2009","unstructured":"Basal E, Eghbali-Fatourechi GZ, Kalli KR, Hartmann LC, Goodman KM, Goode EL, Kamen BA, Low PS, Knutson KL: Functional folate receptor alpha is elevated in the blood of ovarian cancer patients. PLoS One. 2009, 4: e6292-10.1371\/journal.pone.0006292.","journal-title":"PLoS One"},{"key":"3097_CR4","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood.V93.11.3940","volume":"93","author":"JA Reddy","year":"1999","unstructured":"Reddy JA, Haneline LS, Srour EF, Antony AC, Clapp DW, Low PS: Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. Blood. 1999, 93: 3940-3948.","journal-title":"Blood"},{"key":"3097_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1182\/blood-2008-04-150789","volume":"113","author":"W Xia","year":"2009","unstructured":"Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS: A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood. 2009, 113: 438-446.","journal-title":"Blood"},{"key":"3097_CR6","first-page":"6","volume":"7","author":"W Ebel","year":"2007","unstructured":"Ebel W, Routhier EL, Foley B, Jacob S, McDonough JM, Patel RK, Turchin HA, Chao Q, Kline JB, Old LJ, Phillips MD, Nicolaides NC, Sass PM, Grasso L: Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007, 7: 6-","journal-title":"Cancer Immun"},{"key":"3097_CR7","first-page":"2448","volume":"54","author":"LR Coney","year":"1994","unstructured":"Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR: Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res. 1994, 54: 2448-2455.","journal-title":"Cancer Res"},{"key":"3097_CR8","first-page":"4146","volume":"58","author":"C Melani","year":"1998","unstructured":"Melani C, Figini M, Nicosia D, Luison E, Ramakrishna V, Casorati G, Parmiani G, Eshhar Z, Canevari S, Colombo MP: Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody. Cancer Res. 1998, 58: 4146-4154.","journal-title":"Cancer Res"},{"key":"3097_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00262-009-0667-x","volume":"58","author":"T Nagai","year":"2009","unstructured":"Nagai T, Tanaka M, Tsuneyoshi Y, Xu B, Michie SA, Hasui K, Hirano H, Arita K, Matsuyama T: Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta. Cancer Immunol Immunother. 2009, 58: 1577-1586. 10.1007\/s00262-009-0667-x.","journal-title":"Cancer Immunol Immunother"},{"key":"3097_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/art.24219","volume":"60","author":"JW van der Heijden","year":"2009","unstructured":"van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, van der Laken CJ, Lems WF, Jackman AL, Kraan MC, Tak PP, Ratnam M, Jansen G: Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum. 2009, 60: 12-21. 10.1002\/art.24219.","journal-title":"Arthritis Rheum"},{"key":"3097_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/mp0700615","volume":"4","author":"B Varghese","year":"2007","unstructured":"Varghese B, Haase N, Low PS: Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. Mol Pharm. 2007, 4: 679-685. 10.1021\/mp0700615.","journal-title":"Mol Pharm"},{"key":"3097_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM: The many faces of macrophage activation. J Leukoc Biol. 2003, 73: 209-212. 10.1189\/jlb.0602325.","journal-title":"J Leukoc Biol"},{"key":"3097_CR13","first-page":"719","volume":"21","author":"R Nagayoshi","year":"2003","unstructured":"Nagayoshi R, Nakamura M, Ijiri K, Yoshida H, Komiya S, Matsuyama T: LY309887, antifolate via the folate receptor suppresses murine type II collagen-induced arthritis. Clin Exp Rheumatol. 2003, 21: 719-725.","journal-title":"Clin Exp Rheumatol"},{"key":"3097_CR14","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/ar1944","volume":"8","author":"CM Paulos","year":"2006","unstructured":"Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS: Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther. 2006, 8: R77-10.1186\/ar1944.","journal-title":"Arthritis Res Ther"},{"key":"3097_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.addr.2004.01.012","volume":"56","author":"CM Paulos","year":"2004","unstructured":"Paulos CM, Turk MJ, Breur GJ, Low PS: Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev. 2004, 56: 1205-1217. 10.1016\/j.addr.2004.01.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"3097_CR16","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/sj.leu.2404786","volume":"21","author":"BW Blaser","year":"2007","unstructured":"Blaser BW, Gonit M, Qi H, Shatnawi A, Guimond M, Lee RJ, Ratnam M: Induction of folate receptor type beta in a bone marrow engraftment model of acute myelogenous leukemia. Leukemia. 2007, 21: 2233-2235. 10.1038\/sj.leu.2404786.","journal-title":"Leukemia"},{"key":"3097_CR17","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1158\/0008-5472.CAN-09-2050","volume":"69","author":"A Puig-Kroger","year":"2009","unstructured":"Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, Samaniego R, Corcuera MT, Gomez-Aguado F, Ratnam M, Sanchez-Mateos P, Corbi AL: Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory\/regulatory macrophages. Cancer Res. 2009, 69: 9395-9403. 10.1158\/0008-5472.CAN-09-2050.","journal-title":"Cancer Res"},{"key":"3097_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/1535-7163.MCT-05-0252","volume":"5","author":"Y Feng","year":"2006","unstructured":"Feng Y, Zhu Z, Xiao X, Choudhry V, Barrett JC, Dimitrov DS: Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function. Mol Cancer Ther. 2006, 5: 114-120. 10.1158\/1535-7163.MCT-05-0252.","journal-title":"Mol Cancer Ther"},{"key":"3097_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1158\/1535-7163.MCT-08-0945","volume":"8","author":"Y Feng","year":"2009","unstructured":"Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS: A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Mol Cancer Ther. 2009, 8: 1113-1118. 10.1158\/1535-7163.MCT-08-0945.","journal-title":"Mol Cancer Ther"},{"key":"3097_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/0022-2836(84)90278-X","volume":"180","author":"D Zanette","year":"1984","unstructured":"Zanette D, Monaco HL, Zanotti G, Spadon P: Crystallization of hen eggwhite riboflavin-binding protein. J Mol Biol. 1984, 180: 1185-1187. 10.1016\/0022-2836(84)90278-X.","journal-title":"J Mol Biol"},{"issue":"Pt 3","key":"3097_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1042\/bj3270759","volume":"327","author":"F Shen","year":"1997","unstructured":"Shen F, Wang H, Zheng X, Ratnam M: Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites. Biochem J. 1997, 327 (Pt 3): 759-764.","journal-title":"Biochem J"},{"key":"3097_CR22","first-page":"97","volume":"7","author":"RM Schultz","year":"1995","unstructured":"Schultz RM, Andis SL, Shackelford KA, Gates SB, Ratnam M, Mendelsohn LG, Shih C, Grindey GB: Role of membrane-associated folate binding protein in the cytotoxicity of antifolates in KB, IGROV1, and L1210A cells. Oncol Res. 1995, 7: 97-102.","journal-title":"Oncol Res"},{"key":"3097_CR23","first-page":"253","volume":"27","author":"EL Matteson","year":"2009","unstructured":"Matteson EL, Lowe VJ, Prendergast FG, Crowson CS, Moder KG, Morgenstern DE, Messmann RA, Low PS: Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol. 2009, 27: 253-259.","journal-title":"Clin Exp Rheumatol"},{"key":"3097_CR24","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1158\/0008-5472.CAN-05-4048","volume":"66","author":"H Qi","year":"2006","unstructured":"Qi H, Ratnam M: Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. Cancer Res. 2006, 66: 5875-5882. 10.1158\/0008-5472.CAN-05-4048.","journal-title":"Cancer Res"},{"key":"3097_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.nu.02.070182.001305","volume":"2","author":"C Wagner","year":"1982","unstructured":"Wagner C: Cellular folate binding proteins; function and significance. Annu Rev Nutr. 1982, 2: 229-248. 10.1146\/annurev.nu.02.070182.001305.","journal-title":"Annu Rev Nutr"},{"key":"3097_CR26","unstructured":"ClinicalTrials.gov homepage. [http:\/\/www.ClinicalTrials.gov]"},{"key":"3097_CR27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood.V100.2.594","volume":"100","author":"XQ Pan","year":"2002","unstructured":"Pan XQ, Zheng X, Shi G, Wang H, Ratnam M, Lee RJ: Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood. 2002, 100: 594-602. 10.1182\/blood.V100.2.594.","journal-title":"Blood"},{"key":"3097_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/ar7000815","volume":"41","author":"PS Low","year":"2008","unstructured":"Low PS, Henne WA, Doorneweerd DD: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 2008, 41: 120-129. 10.1021\/ar7000815.","journal-title":"Acc Chem Res"},{"key":"3097_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0140-6736(99)03227-4","volume":"354","author":"JM Lawrence","year":"1999","unstructured":"Lawrence JM, Petitti DB, Watkins M, Umekubo MA: Trends in serum folate after food fortification. Lancet. 1999, 354: 915-916. 10.1016\/S0140-6736(99)03227-4.","journal-title":"Lancet"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3312\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:03:42Z","timestamp":1728385422000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,8]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,4]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1186\/ar3312","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,8]]},"assertion":[{"value":"10 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R59"}}